🇺🇸 FDA
Patent

US 8252538

MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

granted A61PA61P35/00

Quick answer

US patent 8252538 (MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00